Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 2: ulcerative colitis [0.03%]
英国胃肠病学会2025年成人炎症性肠病指南（下）：溃疡性结肠炎
Thomas D Butler,Jonathan P Segal
Thomas D Butler
This guideline review summarises the key recommendations for the diagnosis and management of ulcerative colitis from the updated 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults.
Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 1: Crohn's disease [0.03%]
英国胃肠病学会成人炎症性肠病2025指南 第一部分：克罗恩病
Thomas D Butler,Jonathan P Segal
Thomas D Butler
This guideline review summarises the key recommendations for the diagnosis and management of Crohn's disease from the updated 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults.
Joseph Cooney,Spyros I Siakavellas,Peter L Chiodini et al.
Joseph Cooney et al.
With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presen...
Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study [0.03%]
优化疑似炎症性肠病急会诊的分诊：伯明翰疑似炎症性肠病队列研究的结果分析
Peter Rimmer,Jonathan Cheesbrough,Jane Harris et al.
Peter Rimmer et al.
Objective: Diagnostic delays in inflammatory bowel disease (IBD) result in adverse outcomes. We report a bespoke diagnostic pathway to assess how best to combine clinical history and faecal calprotectin (FCP) for early di...
Liver transplant assessment for hepatocellular carcinoma: a single-centre experience [0.03%]
肝细胞癌的肝脏移植评估：单中心经验
Rosemary Elizabeth Faulkes,Sean Morris,Oliwia Bolimowska et al.
Rosemary Elizabeth Faulkes et al.
Objective: The incidence of hepatocellular carcinoma (HCC) continues to rise dramatically in the UK. Liver transplantation offers a potential cure and there is a large body of evidence demonstrating good outcomes. However...
Correction: Recent advances in the diagnosis and management of amoebiasis [0.03%]
关于“阿米巴病诊断和治疗近况”的更正及相关评论摘要
[This corrects the article DOI: 10.1136/flgastro-2023-102554.]. © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial ...
Published Erratum
Frontline gastroenterology. 2025 Apr 8;16(3):e2. DOI:10.1136/flgastro-2023-102554corr1 2025
Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study [0.03%]
乌帕替尼治疗克罗恩病的现实世界有效性：英国多中心回顾性队列研究
Alexander Thomas Elford,Maria Bishara,Nikolas Plevris et al.
Alexander Thomas Elford et al.
Background: Upadacitinib is a Janus kinase inhibitor, which has recently been approved for treating Crohn's disease. There are limited real-world studies on the outcomes of upadacitinib in Crohn's disease. ...
Significance and structure of clinical research in the UK: an introduction for gastroenterology and hepatology nurses [0.03%]
英国临床研究的意义和结构：胃肠病和肝病护士入门指南
Billye J Olsen,Karen Kemp,Rachel Campbell et al.
Billye J Olsen et al.
This is the first of two articles from the joint British Society of Gastroenterology Nurses association and Research Committee working group. The group is dedicated to signposting and improving access to research for specialist nurses worki...
What is the clinical significance of low serum amylase? Systematic review of the conditions associated with low serum amylase [0.03%]
血清淀粉酶降低的临床意义是什么？系统性回顾相关疾病状况
Mustafa Jalal,Sebastine A Gbadegesin,Nadeem Tehami et al.
Mustafa Jalal et al.
Objective: Most studies have assessed the impact of elevated serum amylase levels in clinical practice, but only a few have investigated the significance of low serum amylase. We therefore, aimed to review the literature ...
R Mark Beattie
R Mark Beattie